DO
BMY icon

denkapparat Operations’s Bristol-Myers Squibb BMY Stock Holding History

denkapparat Operations’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Sell
30,782
-8,322
-21% -$485K 0.77% 15
2025
Q4 		$2.11M Buy
39,104
+3,746
+11% +$180K 1.15% 4
2025
Q3 		$1.59M Buy
35,358
+11,154
+46% +$521K 1.02% 6
2025
Q2 		$1.12M Buy
24,204
+9,456
+64% +$464K 0.89% 14
2025
Q1 		$899K Hold
14,748
– – 0.95% 11
2024
Q4 		$834K Buy
+14,748
New +$824K 1.23% 12

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

denkapparat Operations's BMY Position: Q1 2026 in Review

denkapparat Operations reduced its Bristol-Myers Squibb (BMY) stake by 21% in Q1 2026, selling an estimated $485K and leaving 30,782 shares worth $1.87M. The position accounts for 0.77% of the portfolio, ranked #15.

denkapparat Operations first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.11M in Q4 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • denkapparat Operations held 30,782 shares of Bristol-Myers Squibb worth $1.87M as of Q1 2026.
  • denkapparat Operations sold 8,322 Bristol-Myers Squibb shares in Q1 2026, an estimated $485K.
  • Bristol-Myers Squibb made up 0.77% of denkapparat Operations's portfolio in Q1 2026, its #15 holding.
  • denkapparat Operations first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • denkapparat Operations's Bristol-Myers Squibb position peaked at $2.11M in Q4 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on denkapparat Operations's 13F filing for Q1 2026, filed 11 May 2026.